deepblue4you ADMA Biologics ( NASDAQ: ADMA ) shares climbed on Friday after the plasma-based treatment maker announced that KPMG LLP has agreed to function as the company's new independent registered public accounting firm. According to the agreement signed on Thursday, KPMG will take over ADMA's.
Back to Health Page
